Literature DB >> 28662525

Colonic Histological Criteria Predict Development of Pouchitis after Ileal Pouch: Anal Anastomosis for Patients with Ulcerative Colitis.

Toshimitsu Araki1, Kiyoshi Hashimoto, Yoshiki Okita, Hiroyuki Fujikawa, Satoru Kondo, Minako Kobayashi, Masaki Ohi, Yuji Toiyama, Yasuhiro Inoue, Keiichi Uchida, Yasuhiko Mohri, Masato Kusunoki.   

Abstract

BACKGROUND/AIMS: Pouchitis is one of the main complications after ileal pouch-anal anastomosis in patients with ulcerative colitis. The aim of this study was to determine whether the use of colonic histological criteria can predict the development of pouchitis.
METHODOLOGY: We retrospectively reviewed 147 patients' clinical data and performed a histological evaluation of the resected total colon using Tanaka's criteria, which comprise the following 6 factors: ulceration (H1), crypt abscesses (H2), degree of mononuclear cell infiltration (MNCI) (H3), segmental distribution of MNCI (H4), eosinophil infiltration (H5), and extent of disease of resected colon (H6).
RESULTS: The development of pouchitis and chronic pouchitis within 3 years after restoration of gastrointestinal continuity was recognized in 52 (35.4%) and 26 (17.7%) of the 147 patients, respectively. Using various combinations of each score, the H3 + H4 - H5 scores of patients with pouchitis or chronic pouchitis were significantly higher than those of patients without. A H3 + H4 - H5 score of >0.4 was a statistically significant risk factor for the development of both pouchitis and chronic pouchitis.
CONCLUSIONS: The combination of the degree of MNCI, segmental distribution of MNCI, and eosinophil infiltration from histological criteria has utility in predicting the future development of pouchitis, especially chronic pouchitis.
© 2017 S. Karger AG, Basel.

Entities:  

Keywords:  Complication; Histological finding; Mononuclear cell infiltration; Pouchitis; Ulcerative colitis

Mesh:

Year:  2017        PMID: 28662525     DOI: 10.1159/000477268

Source DB:  PubMed          Journal:  Dig Surg        ISSN: 0253-4886            Impact factor:   2.588


  2 in total

1.  Astragaloside IV alleviates the symptoms of experimental ulcerative colitis in vitro and in vivo.

Authors:  Suxiao Wu; Zilan Chen
Journal:  Exp Ther Med       Date:  2019-08-16       Impact factor: 2.447

Review 2.  Pouchitis in inflammatory bowel disease: a review of diagnosis, prognosis, and treatment.

Authors:  Shintaro Akiyama; Victoria Rai; David T Rubin
Journal:  Intest Res       Date:  2020-11-05
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.